A 48-year-old male was diagnosed with lung cancer in 2022. The biopsy revealed as Lung Cancer with Poorly Differentiated Adenocarcinoma, one of the most aggressive forms of lung cancer. This diagnosis was devastating, but he was determined to fight.
2022年，一名48岁的男性被诊断出患有肺癌。活检结果显示，他患上的是低分化腺癌，这是最具侵袭性的肺癌类型之一。这个诊断结果令人心碎，但他决心与病魔抗争。
He began his battle with a series of chemotherapy treatments in Singapore, hoping to contain the disease. This was followed by radiation therapy aimed at addressing the widespread metastatic lymph nodes in his neck. Despite enduring these rigorous treatments, the cancer continued to spread, showing no signs of abating.
他在新加坡开始了他的抗癌之路，首先进行了一系列化疗，希望能控制病情。随后，他接受了针对颈部广泛转移性淋巴结的放疗。然而，尽管经历了这些严苛的治疗，癌症依然继续扩散，没有任何缓解的迹象。Faced with these discouraging results, he sought out other options and learned about ECCT. Deciding to give it a try, he embarked on a new treatment journey. Remarkably, after just a few weeks of ECCT, the tumor bulk began to soften and shrink, giving him a glimmer of hope.
面对这些令人沮丧的结果，他开始寻找其他治疗方案，并从其他幸存者那里了解到ECCT。他决定尝试这种新疗法，开启了一段新的治疗旅程。令人惊讶的是，仅仅几周的ECCT治疗后，肿瘤开始软化并缩小，给他带来了一线希望。
His perseverance paid off. Within a year of starting ECCT, a PET CT scan revealed a significant improvement. The scan showed a much clearer image with far less evidence of cancer, indicating that the treatment was working.
他的坚持得到了回报。一年内，一次PET CT扫描显示出显著的改善。扫描结果显示，图像清晰了很多，癌症的迹象大大减少，表明治疗正在发挥作用。
This remarkable turnaround not only provided him with renewed hope but also inspired others facing similar battles. His journey is a testament to the importance of exploring all available treatment options and never giving up, even when the odds seem insurmountable.
这个非凡的转变不仅为他带来了新的希望，也激励了其他面临类似战斗的人。他的故事证明了探索所有可用治疗选项的重要性，以及在面对看似无法克服的困难时永不放弃的精神。
תגובות